From: Particulate matter exposure and health impacts of urban cyclists: a randomized crossover study
Clinical measure | [Model 3] PNC intake ß-coefficient (95% CI) | [Model 4] PNC intake ß-coefficient in model adjusting for route (95% CI) | Downtown route ß-coefficient (95% CI) | [Model 3] PM2.5 intake ß-coefficient (95% CI) | [Model 4] PM2.5 intake ß-coefficient in model adjusting for route (95% CI) | Downtown route ß-coefficient (95% CI) | [Model 1] Downtown route ß-coefficient (95% CI) |
---|---|---|---|---|---|---|---|
RHI | 0.050 (−0.20, 0.30) | 0.15 (−0.10, 0.40) | −0.50 (−0.90, −0.10) | 0.0010 (−0.091, 0.093) | 0.017 (−0.073, 0.11) | −0.46 (−0.83, −0.089) | −0.43 (−0.79, −0.079) |
FEV1 (mL) | 20 (−26, 66) | 21 (−29, 70) | −3.3 (−74, 67) | −0.64 (−17, 16) | −0.20 (−17, 16) | −13 (−80, 55) | 0.81 (−60, 62) |
FVC (mL) | −33 (− 109, 43) | −46 (−130, 34) | 55 (−60, 170) | −0.79 (−29, 27) | −1.5 (−30, 27) | 20 (−91, 130) | 28 (−74, 130) |
CRP (μg/dL) | 1.7 (−26, 30) | 1.2 (−29, 31) | 2.1 (−44, 49) | −0.072 (−7.7, 7.6) | −0.77 (−8.5, 7.0) | 19 (−13, 50) | 2.3 (−39, 43) |
IL-6 (pg/mL) | 0.55 (−0.53, 1.6) | 0.36 (−0.76, 1.5) | 1.1 (−0.62, 2.8) | 0.17 (−0.22, 0.57) | 0.13 (−0.26, 0.53) | 1.2 (−0.52, 2.8) | 1.2 (−0.43, 2.7) |
8-OHdG (ng/mL) | 15 (−25, 54) | 2.8 (−41, 47) | 32 (−25, 88) | 2.2 (−11, 15) | −0.037 (−13, 13) | 39 (−12, 90) | 30 (−17, 78) |